Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine.
Deschuyteneer M, Elouahabi A, ... , Deschamps M
2010 in Human vaccines
1 annotation
| Correct |
no team
|
09/14/13 00:00 | 08/23/24 21:40 | P03101 | GO:0039620 | ECO:0000315 | 20953154 | Aajones4 | View |
Loading…
Loading…